Ann Marie Navar, MD, PhD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St., Box 3850, Durham, NC 27705
Phone (919) 684-8111
In Their Words

Education and Training

  • Cardiovascular Disease Fellowship, Duke University School of Medicine, 2013 - 2016
  • Internal Medicine and Pediatrics Residency, Duke University School of Medicine, 2009 - 2013
  • Ph.D., Johns Hopkins University, 2009
  • M.D., Duke University School of Medicine, 2009
  • M.H.S., Johns Hopkins University, 2005


Pagidipati, Neha J., Ann Marie Navar, Karen S. Pieper, Jennifer B. Green, M Angelyn Bethel, Paul W. Armstrong, Robert G. Josse, et al. “Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)..” Circulation 136, no. 13 (September 26, 2017): 1193–1203.

Full Text

Fanaroff, Alexander C., Matthew T. Roe, Robert M. Clare, Yuliya Lokhnygina, Ann Marie Navar, Robert P. Giugliano, Stephen D. Wiviott, Andrew M. Tershakovec, Eugene Braunwald, and Michael A. Blazing. “Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes..” J Am Heart Assoc 6, no. 9 (September 18, 2017).

Full Text

Goldstein, Benjamin A., Ann Marie Navar, and Rickey E. Carter. “Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges..” Eur Heart J 38, no. 23 (June 14, 2017): 1805–14.

Full Text

Pencina, M., A. M. Navar, D. Wojdyla, E. D. Peterson, and D. Gee. “LEVERAGING OPEN DATA TO CREATE NEW INSIGHTS IN CARDIOVASCULAR EPIDEMIOLOGY.” In Value in Health, 20:A264–A264. ELSEVIER SCIENCE INC, 2017.


Pagidipati, Neha J., Ann Marie Navar, Hillary Mulder, Allan D. Sniderman, Eric D. Peterson, and Michael J. Pencina. “Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines..” Jama 317, no. 15 (April 18, 2017): 1563–67.

Full Text

Stolker, Joshua M., David J. Cohen, Kevin F. Kennedy, Michael J. Pencina, Suzanne V. Arnold, Neal S. Kleiman, John A. Spertus, and John A. EVENT Investigators. “Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement..” Cardiovasc Revasc Med 18, no. 3 (April 2017): 169–76.

Full Text